Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −3.8% | −8.2% | −6.9% | −15.1% | +0.4% | +5.3% | +56.0% | +7.9% | — | +17.3% |
| Peer average | −2.3% | −6.5% | −6.1% | −9.7% | +8.7% | +14.8% | +44.7% | +21.2% | +149.7% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$20 of every $1,000 in MMSC is Xometry,
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | XMTRXometry, () | Industrials | 1.97% | $197.23 | 8,628 | $961K |
| 2 | —US Dollar | — | 1.93% | $192.87 | 940K | $940K |
| 3 | FROGJFrog | Technology | 1.93% | $192.60 | 8,589 | $939K |
| 4 | NTSKNetskope, () | Technology | 1.67% | $166.54 | 33K | $812K |
| 5 | ZETAZETA Global () | Technology | 1.61% | $160.96 | 24K | $784K |
| 6 | OLLIOllie's Bargain Outlet | Consumer Defensive | 1.58% | $157.51 | 8,127 | $768K |
| 7 | SAILSailPoint | Technology | 1.45% | $145.34 | 32K | $708K |
| 8 | VRNSVaronis Systems | Technology | 1.40% | $140.36 | 14K | $684K |
| 9 | TVTXTravere Therapeutics | Healthcare | 1.30% | $129.76 | 13K | $632K |
| 10 | GHGuardant Health | Healthcare | 1.26% | $125.84 | 4,212 | $613K |
| 11 | SYRESpyre Therapeutics | Healthcare | 1.22% | $122.12 | 6,095 | $595K |
| 12 | RGENRepligen | Healthcare | 1.13% | $112.56 | 3,221 | $549K |
| 13 | PTGXProtagonist Therapeutics | Healthcare | 1.12% | $111.68 | 4,388 | $544K |
| 14 | LGNDLigand Pharmaceuticals () | Healthcare | 1.00% | $100.34 | 1,704 | $489K |
| 15 | TWSTTwist Bioscience | Healthcare | 1.00% | $100.31 | 4,379 | $489K |
of the $573B in 112 Small cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | XMTR | Xometry, () | 1.97% |
| 2 | FROG | JFrog | 1.93% |
| 3 | NTSK | Netskope, () | 1.67% |
| 4 | ZETA | ZETA Global () | 1.61% |
| 5 | OLLI | Ollie's Bargain Outlet | 1.58% |
| 6 | SAIL | SailPoint | 1.45% |
| 7 | VRNS | Varonis Systems | 1.40% |
| 8 | TVTX | Travere Therapeutics | 1.30% |
| 9 | GH | Guardant Health | 1.26% |
| 10 | SYRE | Spyre Therapeutics | 1.22% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 13, 2024 | Dec 31, 2024 | $0.0854 |